Loading…
Synthesis of oligosaccharides by bacterial enzymes
Many human pathogens initiate disease by utilizing their microbial adhesin proteins to attach to glycoconjugates on host cell mucosal surfaces. Soluble oligosaccharides of identical or similar structure to these naturally occurring ligands can both prevent bacterial attachment as well as mediate the...
Saved in:
Published in: | Glycoconjugate journal 1999-02, Vol.16 (2), p.141-146 |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c312t-65e399d2b7fcbc476e6d06f0e0082a7beab8766f105ac54be7133abd322514d03 |
---|---|
cites | |
container_end_page | 146 |
container_issue | 2 |
container_start_page | 141 |
container_title | Glycoconjugate journal |
container_volume | 16 |
creator | Johnson, K F |
description | Many human pathogens initiate disease by utilizing their microbial adhesin proteins to attach to glycoconjugates on host cell mucosal surfaces. Soluble oligosaccharides of identical or similar structure to these naturally occurring ligands can both prevent bacterial attachment as well as mediate the release of attached bacteria. Since it has not been possible to isolate large quantities of these compounds, we have developed enzyme-based technologies to synthesize several relevant human oligosaccharides. Using cloned bacterial glycosyltransferases, we can synthesize several hundred grams of these oligosaccharides at a time. The availability of these large quantities will allow these compounds to be tested as anti-adhesive pharmaceutical agents as well as lead to expanded practical applications. |
doi_str_mv | 10.1023/A:1026440509859 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_954579142</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>954579142</sourcerecordid><originalsourceid>FETCH-LOGICAL-c312t-65e399d2b7fcbc476e6d06f0e0082a7beab8766f105ac54be7133abd322514d03</originalsourceid><addsrcrecordid>eNp90DtPwzAUBWALgWgpzGwoYoApcP222aqKl1SJAZgj27mhqfIocTKEX08kysLAdJZPR_ceQs4p3FBg_HZ5N4USAiRYI-0BmVOpeSqsUYdkDsywFMDAjJzEuAUALZg5JjMKijJB-Zyw17HpNxjLmLRF0lblRxtdCBvXlTnGxI-Jd6HHrnRVgs3XWGM8JUeFqyKe7XNB3h_u31ZP6frl8Xm1XKeBU9anSiK3NmdeF8EHoRWqHFQBOB3EnPbovNFKFRSkC1J41JRz53POmKQiB74g1z-9u679HDD2WV3GgFXlGmyHmFkppLZUsEle_SuV5dpQIyZ4-Qdu26Frpi8yLY0BI7SZ0MUeDb7GPNt1Ze26MfsdjX8DB_Fsdw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>758808478</pqid></control><display><type>article</type><title>Synthesis of oligosaccharides by bacterial enzymes</title><source>Springer Link</source><creator>Johnson, K F</creator><creatorcontrib>Johnson, K F</creatorcontrib><description>Many human pathogens initiate disease by utilizing their microbial adhesin proteins to attach to glycoconjugates on host cell mucosal surfaces. Soluble oligosaccharides of identical or similar structure to these naturally occurring ligands can both prevent bacterial attachment as well as mediate the release of attached bacteria. Since it has not been possible to isolate large quantities of these compounds, we have developed enzyme-based technologies to synthesize several relevant human oligosaccharides. Using cloned bacterial glycosyltransferases, we can synthesize several hundred grams of these oligosaccharides at a time. The availability of these large quantities will allow these compounds to be tested as anti-adhesive pharmaceutical agents as well as lead to expanded practical applications.</description><identifier>ISSN: 0282-0080</identifier><identifier>EISSN: 1573-4986</identifier><identifier>DOI: 10.1023/A:1026440509859</identifier><identifier>PMID: 10612413</identifier><language>eng</language><publisher>United States: Springer Nature B.V</publisher><subject>Adhesins ; Bacteria ; Bacteria - enzymology ; Bacteria - genetics ; Biotechnology ; Carbohydrate Sequence ; Enzymes ; Gene Expression ; Genetic Vectors ; Globosides - biosynthesis ; glycoconjugates ; Glycosyltransferase ; Glycosyltransferases - biosynthesis ; Glycosyltransferases - metabolism ; Humans ; Molecular Sequence Data ; Mucosa ; oligosaccharides ; Oligosaccharides - biosynthesis ; Pathogens ; Pharmaceuticals ; Recombinant Proteins - biosynthesis ; Recombinant Proteins - metabolism ; Trisaccharides - biosynthesis</subject><ispartof>Glycoconjugate journal, 1999-02, Vol.16 (2), p.141-146</ispartof><rights>Kluwer Academic Publishers 1999</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c312t-65e399d2b7fcbc476e6d06f0e0082a7beab8766f105ac54be7133abd322514d03</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10612413$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Johnson, K F</creatorcontrib><title>Synthesis of oligosaccharides by bacterial enzymes</title><title>Glycoconjugate journal</title><addtitle>Glycoconj J</addtitle><description>Many human pathogens initiate disease by utilizing their microbial adhesin proteins to attach to glycoconjugates on host cell mucosal surfaces. Soluble oligosaccharides of identical or similar structure to these naturally occurring ligands can both prevent bacterial attachment as well as mediate the release of attached bacteria. Since it has not been possible to isolate large quantities of these compounds, we have developed enzyme-based technologies to synthesize several relevant human oligosaccharides. Using cloned bacterial glycosyltransferases, we can synthesize several hundred grams of these oligosaccharides at a time. The availability of these large quantities will allow these compounds to be tested as anti-adhesive pharmaceutical agents as well as lead to expanded practical applications.</description><subject>Adhesins</subject><subject>Bacteria</subject><subject>Bacteria - enzymology</subject><subject>Bacteria - genetics</subject><subject>Biotechnology</subject><subject>Carbohydrate Sequence</subject><subject>Enzymes</subject><subject>Gene Expression</subject><subject>Genetic Vectors</subject><subject>Globosides - biosynthesis</subject><subject>glycoconjugates</subject><subject>Glycosyltransferase</subject><subject>Glycosyltransferases - biosynthesis</subject><subject>Glycosyltransferases - metabolism</subject><subject>Humans</subject><subject>Molecular Sequence Data</subject><subject>Mucosa</subject><subject>oligosaccharides</subject><subject>Oligosaccharides - biosynthesis</subject><subject>Pathogens</subject><subject>Pharmaceuticals</subject><subject>Recombinant Proteins - biosynthesis</subject><subject>Recombinant Proteins - metabolism</subject><subject>Trisaccharides - biosynthesis</subject><issn>0282-0080</issn><issn>1573-4986</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNp90DtPwzAUBWALgWgpzGwoYoApcP222aqKl1SJAZgj27mhqfIocTKEX08kysLAdJZPR_ceQs4p3FBg_HZ5N4USAiRYI-0BmVOpeSqsUYdkDsywFMDAjJzEuAUALZg5JjMKijJB-Zyw17HpNxjLmLRF0lblRxtdCBvXlTnGxI-Jd6HHrnRVgs3XWGM8JUeFqyKe7XNB3h_u31ZP6frl8Xm1XKeBU9anSiK3NmdeF8EHoRWqHFQBOB3EnPbovNFKFRSkC1J41JRz53POmKQiB74g1z-9u679HDD2WV3GgFXlGmyHmFkppLZUsEle_SuV5dpQIyZ4-Qdu26Frpi8yLY0BI7SZ0MUeDb7GPNt1Ze26MfsdjX8DB_Fsdw</recordid><startdate>19990201</startdate><enddate>19990201</enddate><creator>Johnson, K F</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>7QL</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>19990201</creationdate><title>Synthesis of oligosaccharides by bacterial enzymes</title><author>Johnson, K F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c312t-65e399d2b7fcbc476e6d06f0e0082a7beab8766f105ac54be7133abd322514d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adhesins</topic><topic>Bacteria</topic><topic>Bacteria - enzymology</topic><topic>Bacteria - genetics</topic><topic>Biotechnology</topic><topic>Carbohydrate Sequence</topic><topic>Enzymes</topic><topic>Gene Expression</topic><topic>Genetic Vectors</topic><topic>Globosides - biosynthesis</topic><topic>glycoconjugates</topic><topic>Glycosyltransferase</topic><topic>Glycosyltransferases - biosynthesis</topic><topic>Glycosyltransferases - metabolism</topic><topic>Humans</topic><topic>Molecular Sequence Data</topic><topic>Mucosa</topic><topic>oligosaccharides</topic><topic>Oligosaccharides - biosynthesis</topic><topic>Pathogens</topic><topic>Pharmaceuticals</topic><topic>Recombinant Proteins - biosynthesis</topic><topic>Recombinant Proteins - metabolism</topic><topic>Trisaccharides - biosynthesis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Johnson, K F</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Glycoconjugate journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Johnson, K F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis of oligosaccharides by bacterial enzymes</atitle><jtitle>Glycoconjugate journal</jtitle><addtitle>Glycoconj J</addtitle><date>1999-02-01</date><risdate>1999</risdate><volume>16</volume><issue>2</issue><spage>141</spage><epage>146</epage><pages>141-146</pages><issn>0282-0080</issn><eissn>1573-4986</eissn><abstract>Many human pathogens initiate disease by utilizing their microbial adhesin proteins to attach to glycoconjugates on host cell mucosal surfaces. Soluble oligosaccharides of identical or similar structure to these naturally occurring ligands can both prevent bacterial attachment as well as mediate the release of attached bacteria. Since it has not been possible to isolate large quantities of these compounds, we have developed enzyme-based technologies to synthesize several relevant human oligosaccharides. Using cloned bacterial glycosyltransferases, we can synthesize several hundred grams of these oligosaccharides at a time. The availability of these large quantities will allow these compounds to be tested as anti-adhesive pharmaceutical agents as well as lead to expanded practical applications.</abstract><cop>United States</cop><pub>Springer Nature B.V</pub><pmid>10612413</pmid><doi>10.1023/A:1026440509859</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0282-0080 |
ispartof | Glycoconjugate journal, 1999-02, Vol.16 (2), p.141-146 |
issn | 0282-0080 1573-4986 |
language | eng |
recordid | cdi_proquest_miscellaneous_954579142 |
source | Springer Link |
subjects | Adhesins Bacteria Bacteria - enzymology Bacteria - genetics Biotechnology Carbohydrate Sequence Enzymes Gene Expression Genetic Vectors Globosides - biosynthesis glycoconjugates Glycosyltransferase Glycosyltransferases - biosynthesis Glycosyltransferases - metabolism Humans Molecular Sequence Data Mucosa oligosaccharides Oligosaccharides - biosynthesis Pathogens Pharmaceuticals Recombinant Proteins - biosynthesis Recombinant Proteins - metabolism Trisaccharides - biosynthesis |
title | Synthesis of oligosaccharides by bacterial enzymes |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T17%3A26%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20of%20oligosaccharides%20by%20bacterial%20enzymes&rft.jtitle=Glycoconjugate%20journal&rft.au=Johnson,%20K%20F&rft.date=1999-02-01&rft.volume=16&rft.issue=2&rft.spage=141&rft.epage=146&rft.pages=141-146&rft.issn=0282-0080&rft.eissn=1573-4986&rft_id=info:doi/10.1023/A:1026440509859&rft_dat=%3Cproquest_pubme%3E954579142%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c312t-65e399d2b7fcbc476e6d06f0e0082a7beab8766f105ac54be7133abd322514d03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=758808478&rft_id=info:pmid/10612413&rfr_iscdi=true |